TickerFactsScreenerDevelopers

Nuo Therapeutics, Inc. (AURX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$3.54M2011: -$4.24M2012: -$11.39M2017: -$4.90M2018: -$874.4K2019: -$921.7K2020: -$53.8K2021: -$120.0K2022: -$3.71M2023: -$3.17M2024: -$2.23M2025: -$865.0K-$865.0K
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$865.0K+61.2%
2024-$2.23M+29.6%
2023-$3.17M+14.5%
2022-$3.71M-2989.6%
2021-$120.0K-122.9%
2020-$53.8K+94.2%
2019-$921.7K-5.4%
2018-$874.4K+82.2%
2017-$4.90M—
2012-$11.39M-168.7%
2011-$4.24M-19.9%
2010-$3.54M—